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ABSTRACT
Objectives To investigate, prior to an oncology 
consultation, the use of a pre-prepared list of evidence 
based questions, Question Prompt Sheet (QPS), compared 
with a Question List (QL), a patient self-generated list of 
questions.
Design Multi-centred, randomised controlled trial.
Setting Secondary-care patients attending three 
outpatient oncology clinics in Northern Italy.
Participants 308 women completed the study. Inclusion 
criteria were an age between 18 and 75 years, a recent 
diagnosis of early stage, non-metastatic breast cancer, 
adequate Italian language skills, no previous oncology 
visits and no evidence of cognitive impairment.
Intervention Patients received the QPS or the QL prior 
to the consultation, completed it without suggestion or 
coaching session and delivered back before the visit.The 
consultations were audio-recorded and analysed for the 
number and content of questions. Multilevel linear models 
were used to compare the two groups.
Outcome measures The primary outcome was the 
comparison of questions asked between QPS and QL group. 
Secondary outcomes included satisfaction about questions 
asked, satisfaction with decision, and level of anxiety.
Results Patients in the QPS and QL group asked 13 
and 16 questions respectively. The difference was not 
significant (b=1.7, CI –0.3 to 3.6, p=0.10). A mean of 22 
questions was selected in the QPS, while a mean of 2 
questions was written in the QL. Patients in the QPS group 
were significantly less satisfied (t=3.60, p<0.01) with 
questions asked but wanted less additional information 
(t=2.20, p<0.05). Levels of patient decisional satisfaction 
were equivalent between groups. Similarly, anxiety levels 
were equal between groups prior to the consultation and 
decreased in similar way after the consultation.
Conclusions Both interventions have similar impact on 
patients’ participation in terms of question asking during 
the consultation. Future research is needed in order to 
explore which components of the interventions are really 
useful and efficacious.
Trial registration  ClinicalTrials. gov NCT01510964
InTRODuCTIOn
In recent years, the patient-physician relation-
ship has been evolving largely due to changes 
in patient preferences for more information1 
and a more active role in the decision making 
process regarding their illness.
Patient centred communication has 
become the gold standard for excellence 
in clinical communication. It consists of 
clinicians eliciting and understanding their 
patients’ perspectives and social contexts, 
reaching a shared understanding and 
empowering patients by offering meaningful 
involvement in treatments decisions.2
Strengths and limitations of this study
 ► This is the first trial in Europe comparing two 
different methods of promoting question asking 
prior to an oncology consultation.
 ► The strength of the study lies in the use of a rigorous 
randomised controlled methodology and, differently 
from previous studies, oncologists were blinded to 
which experimental group to which participants 
were randomised thus allowing the evaluation of the 
real power of the intervention.
 ► In order to ensure that the oncologists were blind to 
their patient experimental group assignment, copies 
of the completed QPS or QL were not provided for 
patients to use during their consultation to serve 
as a reminder, so it may be that the number of 
questions asked could be mediated by the patient's 
recall ability.
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One approach to promote patient-centred communi-
cation is to provide mechanisms to involve and support 
active participation in consultations, by encouraging 
patients to ask questions. Asking questions can be consid-
ered a first index of active participation in the discussion 
and an expression, at the same time, of a patient’s most 
immediate information needs.3–7 Asking questions can 
lead to positive benefits for cancer patients, including 
greater satisfaction and better treatment adherence.8 9
Two main techniques have been tested in the oncology 
setting to promote question asking. First, Question 
Listing (QL), before the visit with their oncologist, 
patients have been encouraged to generate their own list 
of questions10 about their cancer and treatment options 
through a coaching process with an independent assis-
tant.11–13 A consultation plan is then generated and given 
to the patient and the oncologist to be used as a visual 
aid during the consultation.14 Second a Question Prompt 
Sheet QPS), before a consultation with their oncologist, 
patients have been provided with a pre-prepared list of 
evidence based questions, a QPS that prompt patients 
to consider novel topics before they see their oncologist 
and serves to remind patients to raise these questions 
with their oncologist during their consultation.15–19 In 
the oncology setting, using the QPS coupled with oncolo-
gist endorsement of question asking, had shown that: (a) 
patients were encouraged to ask more questions, in partic-
ular about sensitive and difficult topics such as prognosis, 
diagnosis, and issues surrounding end of life care15 17 18; 
(b) the quality of the information exchanged between 
the physicians and patients had been increased,4 15–17 and 
(c) patient outcomes had been improved (eg, enhanced 
information recall and reduced level of anxiety during 
the consultation).15 17 18 20 21
In this Randomised Controlled Trial (RCT) we assessed 
whether there was a difference in the efficacy of a Ques-
tion Prompt Sheet (QPS) versus a Question Listing (QL) 
method to increase the number of questions that breast 
cancer patients with early stage disease asked during their 
initial encounter with an oncologist. We also assessed the 
differential impact of each method on patient outcomes. 
This study is innovative in three ways. First, this study 
compared the efficacy of the two interventions with 
each other while previous studies have compared either 
the QPS or QL, with a standard of care control group, 
which risks overestimating the real effect of the inter-
vention.10–13 15–19 Second, moreover, the oncologists in 
this study were blind to their patients’ treatment group 
allocation. In order to achieve this, both the completed 
QPS and QL were collected just before the patient visit. 
This approach enabled the evaluation of the real power 
of the interventions and guarded against the potential 
for Hawthorne effects.22 Third, patients in the QL group 
in this study generated their questions alone without 
coaching or other assistance.
The QPS is a more structured intervention in that 
patients receive many previously prepared, evidence 
based questions in several topic areas that can be selected 
and asked during the consultation. On the other hand, 
the QL intervention requires greater patient effort as 
patients must generate their own question and, in the 
process, they may focus on a limited range of their most 
immediate information needs. For this reason we hypoth-
esised that the use of the QPS, prior to an oncology 
consultation, could further increase the number of 
questions asked in general and by specific topic areas 
(eg, prognosis) compared with the use of the QL. We 
also hypothesised that the use of the QPS would result 
in; a) greater patient satisfaction about the information, 
b) greater patient satisfaction with the treatment deci-
sion and c) less patient anxiety after the consultation 
compared with the use of the QL.
MeThODS
Study design
This study was a multi-centred randomised controlled 
trial in which patients were randomised to the QPS or 
QL in a 1:1 ratio. The randomization sequences were 
generated off-site and stratified by centre by the study 
statistician (MAM). These sequences remained unknown 
to the research assistants involved in the data collec-
tion phase. Both the randomization procedure and 
the treatment allocation techniques were developed to 
fully conceal the allocation from the research assistants, 
patients and oncologists. First, patients were given the 
intervention, either the QPS or QL, in a sealed envelope. 
Once the QPS or QL were completed they were placed 
into the same envelope, resealed and delivered back 
to the research assistant (RA). Second, patients were 
unaware of the detailed contents of the treatment that 
they did not receive, thus patients allocated to the QPS 
did not know the content of the QL intervention. Third, 
Oncologists did not know what type of intervention had 
been completed by the patients before the visit.
The study followed CONSORT guidelines23 and was 
approved by the Ethics Committee of the Hospital Trust 
of Verona and by the Provincial Ethics Committee of 
Brescia. The study protocol has been published else-
where.24
Patients and recruitment
The patient participants were all women with early stage 
breast cancer. Physician participants were the oncologists 
treating these patients in one of three outpatient clinics 
in Northern Italy run by the Hospital Trusts of Verona 
and Brescia.24
To be eligible patients were aged between 18 and 75 
years, had a recent diagnosis of early stage, non-meta-
static breast cancer (from stage 0 (Tis) to stage III), had 
adequate native language skills to complete question-
naires, had not visited any oncologist previously and no 
evidence of cognitive impairment (patients who had 
severe psychiatric or neurological diagnosis that could 
have an impact to cognitive functions were excluded).
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At study commencement oncologists provided written 
informed consent and provided demographic data that 
included their gender, age and years of oncology expe-
rience. Eligible patients were approached in the clinic 
waiting room by the oncology nurse who described the 
study goals and elicited the patient’s interest in partic-
ipating. Interested patients were accompanied to a 
dedicated room and were given detailed information by 
the research assistant. Willing patients provided written 
informed consent to participate in the study including 
consultation audio recording. Patients were then 
randomised to one of the two intervention groups within 
each centre.
Group 1 – Question Prompt Sheet (QPS) – Patients 
were provided with a Question Prompt Sheet.
Group 2 – Self generated Question List (QL) – Patients 
were provided with a blank lined form to write their own 
questions.
Patients completed the QPS or the QL in the clinic 
room in privacy prior to their appointment with their 
oncologist. They were not given a time limit to complete 
either intervention.
Recruitment was conducted between June 2011 and 
May 2013.
Socio-demographic data, such as age, marital status, 
education and employment were collected before the 
randomization along with pre-consultation levels of 
anxiety. All consultations were audio-recorded to allow 
an analysis of the consultation length and of the number 
of questions asked by the patient. Immediately following 
the consultation patients completed three question-
naires that measured post consultation levels of anxiety, 
satisfaction with information and satisfaction with the 
decision.
Question counting
Patients’ questions were defined as ‘utterances in inter-
rogative form that ask for information or clarification’.25 
Six categories were identified, five derived from those 
described in the literature1 15 (symptoms, aetiology, prog-
nosis, prevention and illness management), and one 
specifically added (administrative questions). A code-
book was developed that provided definitions, examples 
and decision rules to guide question classification, by each 
category. Inter-rater reliability was calculated among the 
three coders was calculated based on ten consultations. 
Three coders were utilised due to volume of transcripts 
generated by the study requirements. The results revealed 
an average percent agreement of 62.9% and an accept-
able Cohen's kappa of 0.49.
Subsequently, all interviews were equally distributed 
among the three coders who listened to the audiotapes, 
identified all direct patients’ questions, transcribed them 
verbatim and categorised them using the categories previ-
ously identified.
The primary outcome was the total number of ques-
tions asked and the number of questions within each of 
these content categories.23
Materials
Question Prompt Sheet (QPS)
The QPS is a structured list of 50 evidence-based ques-
tions that patients commonly want to ask their oncologist. 
The original English QPS developed by the Australian 
group3 15–18 26 and largely used both for research and 
clinical purposes was translated and adapted for Italian 
patients in collaboration with the senior author (RB).27
Participants were asked to circle salient questions, if 
any, they would like to ask their oncologist. The main 
topic areas regarded the diagnosis, the prognosis, the 
treatment options and some other additional informa-
tion (eg, costs, support information).
Self-generated Question List (QL)
The QL form is a blank lined paper where participants 
were asked to independently self-generate a list of ques-
tions they would like to ask their oncologist without any 
previously coaching session. Participants were instructed 
to:
‘Please indicate the issues which you want to discuss today 
with your oncologist and the questions you want to ask’.
Questionnaires
Satisfaction with information was measured by a study 
specific questionnaire composed by the three following 
questions:
a) “How much have you been able to ask those questions you 
had previously selected or written?, b) ‘How much did the 
oncologist answer in a clear and comprehensive way?’ and 
c) ‘How much do you feel the need for further information?”.
Responses were recorded on Likert scales with anchors 
at
‘1 – not at all’ and ‘5 – very much so’.
Satisfaction with Decision was measured using the 
Satisfaction With Decision scale (SWD),28 a six item ques-
tionnaire with patients responses reported on a Likert 
scale with anchors at
‘1 – strongly disagree’ and ‘5 – strongly agree’.
The state anxiety level before the consultation was 
assessed using the Spielberger State-Trait Anxiety Inven-
tory-X1 (STAI-X1),29 a validated, widely used measure 
that consists of 20 items with responses reported on a 
Likert scale with anchors at
‘1 – not at all’ and ‘4 – very much so’.
The state anxiety level after the consultation was 
assessed using the STAI-X1/R,30 31 which is a ten-item 
reduced version of the STAI-X1, with responses reported 
in an identical manner.
Anxiety fluctuation before and after the consultation 
was calculated by the difference between the two total 
scores on the 10 items common in both scales. The value 
obtained is called STAI-DIFF.30 31
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See Appendix A for a copy of questionnaires used.
Sample size calculation and statistical analysis
The sample size calculation utilised indicated that we 
need a sample of 300 participants, so that the 50 patients 
in each arm, within the three centres. This number was 
estimated assuming a clinically relevant difference of 
5 questions between QPS and QL group (30% effect 
size). No significant differences in question asking were 
expected between the three centres. The unpaired t-test 
had a power of 80%, a significance level of 5% while 
taking into account a withdrawal rate of 15% (more 
details in the protocol).24
The difference in the number of patient questions 
within the two intervention groups (Aim 1) was assessed 
by a multilevel linear regression. The regression consid-
ered the hierarchical design (patients nested into 
doctors and doctors into centres)32 and was adjusted 
for confounders, introduced as covariates in the model. 
A preliminary exploration using a Pearson’s correlation 
coefficient found that consultation length and presence 
of a companion were significantly correlated with the 
dependent variable (number of questions). Due to a non 
normal distributions, a Wilcoxon non-parametric test was 
conducted to to explore differences between question 
topics desired by patients between experimental groups.
For Aim 2, after having checked for the presence of 
socio-demographic differences among centres, as poten-
tial confounders (with chi-squared test and one-way 
ANOVA, performed for categorical and continuous vari-
ables respectively), Student’s t-tests were carried out to 
explore between group differences in satisfaction with 
information, satisfaction with decision and pre/post 
consultation levels of anxiety.
A data set containing the study data is available in PDF 
format as supplementary material .
ReSulTS
Twenty oncologists were recruited, who were mostly 
female (85%) with an average age of 38.8 years and an 
average 11.3 years of experience as a medical oncologist. 
Each oncologist conducted an average of 15 consulta-
tions for the study (SD=16.9, range 1–52).
Three hundred and twenty-four patients participated in 
the study. One hundred and sixty-four were randomised 
to the QPS group and the remainder to the QL group 
(figure 1). Sixteen audio-recordings were drop out due to 
technical issues. Three hundred and eight female patients 
with a mean age of 55.6 years were finally analysed. The 
average time since diagnosis was 2 months.
Patient demographic variables are shown in table 1. 
Differences between groups on these variables were 
non-significant, indicating that the two groups are similar 
with respect to the above characteristics.
Consultation characteristics
The length of the consultations ranged between 12 and 
129 min with an average of 49 min (SD=19). A family 
member was present in 72% of consultations for both the 
the QPS and QL groups.
The correlation between the consultation length and 
number of questions was 0.45 (p<0.01) while the correla-
tion between the presence of family member and the 
Figure 1 CONSORT diagram. QL, question list; QPS, question prompt sheet.
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number of questions was 0.24 (p<0.01). These two consul-
tation factors were included in the regression model as 
confounding effects without interaction with the two 
intervention arms.
Impact of the two interventions on question asking
The effect of the hierarchical structure of our sample 
(patients nested within doctor and doctor nested within 
centres) was measured by intra-class correlation (ICC) 
which measures the proportion of the total variability 
explained by the between-level variance. The results 
of this analysis revealed that ICC for centre=0.08 and 
ICC (doctor | centre)=0.12 respectively. (For details see 
figure 2). Due to these moderate ICC values33 (more than 
5%) we utilised multilevel techniques in the regression 
model.
The 158 patients in the QPS group selected an average 
of 22 questions (SD=12, range 0–50) each, for an overall 
total of 3392 questions. The 150 patients in the QL group 
self generated an average of of 2.4 questions (SD=2.3, 
range 0–16) for an overall total of 293 questions.
Patients in the QPS group asked their physicians a total 
of 259 of the their 3392 questions(8%). Patients in the 
QL group asked a total of 133 (45%) of their questions
Five patients in the QPS group selected no questions 
and 43 patients in the QL group did generate any of their 
own questions.
Patients in the QPS group asked an average of 13 ques-
tions (SD=9.0) compared with an average of 16 questions 
in the QL group (SD=12.4). The multilevel regression 
estimated this non-significant difference at 1.7 (CI –0.3 to 
3.6, p=0.10), holding the confounding variables constant: 
the consultation length (b=0.3, CI 0.2 to 0.3, p<0.01) and 
the presence of companions (b=
–4.9, CI –7.2 to –2.7, p<0.01). Thus, (1) a patient 
enrolled in the QL group asked, on average, 1.7 more 
questions than a patient enrolled in the QPS group, (2) 
the presence of a companion reduced the number of 
patient’s questions asked (about 5) and (3) that despite 
their assigned group, on average, patient asked more 
questions during longer consultations (a new question 
every 3 min).
Regarding question topics, as shown in table 2, patients 
most commonly asked about illness management (41.2%) 
and administrative issues (32.5%). There were no signifi-
cant differences between the two groups.
Satisfaction with information
We observed significant differences between groups in 
satisfaction with the information. Patients with the QPS 
asked less of their selected questions (t=3.60; p<0.01) 
compared with the QL group and were significantly 
less satisfied with information they received (t=2.38; 
p<0.05). Compared with the QL group, patients in the 
Figure 2 Number of patient’s questions per interview. The box-plot graphs show the frequency distribution within centres and 
bar graphs show the mean values of patients’ questions per doctor, nested in centres.M1, M2 etc.: medical oncologist.
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QPL group reported less need for information (t=2.20; 
p<0.05).
Satisfaction with the decision and anxiety
Patient levels of satisfaction with the decision were equally 
high in both experimental groups. Pre-consultation 
anxiety levels were also equal between the two groups. 
After the consultation, anxiety levels decreased but were 
not significantly different between groups (table 3).
DISCuSSIOn
Patient question asking is now considered an essential 
component of patient centred communication during 
physician – patient consultations. Our knowledge of 
optimal methods to promote question asking is evolving. 
It is important to compare the efficacy of methods of 
promoting question asking and the utility of different 
methods to improve patient outcomes.
In this RCT we hypothesised that patients who had 
selected their question from an evidence based set of ques-
tions, available on the QPS, would ask a greater number 
of questions than patients who self-generated their own 
list of questions on the QL. After taking into account 
consultation length and the presence of companion as 
confounders, we observed no statistical difference in 
question asking between the two groups. Also regarding 
the question topics, there were no statistical differences. 
However patients who utilised the QPS stated that they 
had been less able to ask questions they had previously 
selected, and were less satisfied with the information 
they received, even though they had no more additional 
questions they want to ask when compared with the 
QL group. No differences between groups were found 
regarding the level of satisfaction with decision and the 
level of anxiety.
Previous studies in the field10–13 15–19 showed that, 
compared with a standard care control group, the use 
of either a Question Prompt Sheet or Question Listing 
improved question asking.
Counter to our hypothesis it is noteworthy that the 
use of the QPS and the use of the QL resulted an equal 
number of overall questions asked. This suggests that 
both our interventions, administered without a coaching 
session and not brought into the consultation, are equally 
important to prepare patients to ask questions during their 
consultation. Providing space before the consultation can 
Table 2 Patients questions by topic
QPS QL Wilcoxon test
M (SD) M (SD) z-test p-Value
Symptoms 1.74 (1.86) 2.32 (3.07) –0.46 0.65
Aetiology 0.18 (0.58) 0.31 (0.78) –1.79 0.07
Prognosis 0.45 (0.80) 0.67 (1.27) –1.14 0.25
Prevention 0.94 (1.49) 1.09 (1.60) –0.60 0.55
Illness Management 5.75 (4.88) 6.29 (5.48) –0.79 0.43
Administrative 4.34 (3.44) 5.18 (4.37) –1.25 0.21
M, mean; QL, question list; QPS, question prompt sheet.
Table 3 Questionnaires
QPS QL
M (SD) 95% CI M (SD) 95% CI p-Value
Satisfaction with information
  Questions asked * 3.67 (0.79) 3.5 to 3.8 4.06 (0.82) 3.9 to 4.2 <0.01
  Oncologist’s answers * 4.31 (0.65) 4.2 to 4.4 4.50 (0.63) 4.4 to 4.6 <0.05
  More information * 1.98 (1.00) 1.8 to 2.1 2.29 (1.22) 2.0 to 2.5 <0.05
Satisfaction With Decision 26.50 (3.57) 25.9 to 27.1 27.18 (3.13) 26.6 to 27.7 0.11
Anxiety
  Prior to the consultation 2.38 (0.57) 2.3 to 2.5 2.45 (0.62) 2.3 to 2.5 0.33
  After the consultation 1.94 (0.64) 1.8 to 2.0 1.94 (0.63) 1.8 to 2.0 0.94
  STAI-DIFF† 0.46 (0.66) 0.3 to 0.6 0.50 (0.67) 0.4 to 0.6 0.62
*Mean score of ‘How much do you feel the need for further information?’
*Mean score of ‘How much have you been able to ask those questions you had previously selected on the QPS?/ written in the QL?’
*Mean score of ‘How much did the oncologist answer in a clear and comprehensive way?’
†The STAI-DIFF was usually calculated on total score, here we report the mean score
 M, mean; QL, question list; QPS, question prompt sheet; STAI–DIFF: State-Trait Anxiety Inventory–Difference.
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help patients to focus on their own information needs 
and think about what they want to ask their doctor.
In our sample, the QPS might have reduced the number 
of questions compared with QL by encouraging patients 
to ask more focused and precise questions. This assump-
tion can be supported by the results from a previous 
observational study34 conducted by our group in the same 
context (ie, with patients recruited with the same proce-
dure and with the same clinical and socio-demographic 
characteristics), showing that patients without question 
asking interventions prior to the consultation ask a mean 
of 18 questions (slightly more than 13 questions in this 
sample). This observation highlights the importance of 
question phrasing as important to promote salient ques-
tion asking.
Our finding although not significant, that patients in 
the QL group asked more question than those in the QPS 
group was counter-intuitive. It may be that the number of 
questions asked could be mediated by the patient’s recall 
ability. Thus, patients who self-generate question using 
the QL may produce fewer questions and the generated 
questions may be phrased in salient terms that are easier 
for patients to recall. In the absence of the QPS/QL to 
take into the consultation, it may be that QPS patients 
had more difficulty remembering their desired questions 
than patients in the QL group. This could be supported by 
the fact that patients in the QL group asked more of the 
questions that they had previously written (133 out of 293) 
compared with patients in the QPS group, who asked fewer 
questions (259 out of 3392). It is possible that patients in 
the QPS felt somewhat constrained by the questions they 
had to choose from and therefore asked fewer questions 
that reflect the priority needs. However, these results should 
be deeply analysed, taking into consideration the quality 
of the communication exchange, exploring whether the 
physician has provided information without the patient’s 
request and how the physician answer the patient.
Moreover, in the absence of the QPS/QL to take into 
the consultation, oncologists may have taken the lead 
in determining the course of the medical consultation, 
leaving little space for patients to take sufficiently active 
question asking role in the consultation.
Our finding that consultation length was a confounder 
suggests that Italian oncologists utilise the time spent 
in consultation somewhat differently than oncologists 
from other Western medical cultures. The average 
length of Italian consultation in oncology seems to be 
slightly longer, 49 compared with 30–39 min reported 
by other.15 17 26 Since the number of questions noted, 
regardless of intervention groups is quite similar to other 
studies,15–19 it may be that Italian oncologists spend more 
time giving information when answering patient ques-
tions. A QPS might be more effective in enhancing recall 
of information when the provider receives training in 
how to endorse it and how to encourage patients to ask 
questions from it.35 36
It has been demonstrated in English speaking coun-
tries that a QPS is a useful tool to improve patient’s 
participation during the consultation. However, we 
contend that consultation communication may vary 
across cultures and thus there is the need to explore the 
efficacy of a QPS intervention in Non-English speaking 
countries to better explore cross-cultural differences.36
We feel this study contributes to move our scientific 
knowledge forward by increasing our knowledge of 
cultural influences on question asking and on doctor-pa-
tient communication. More research is needed to 
improve a mutual understanding between countries 
leading to a more fruitful doctor-patient interaction and 
implementing a more effective co-operation and integra-
tion of healthcare policies.
Due to the complexity of the interaction between 
the patient and the oncologist, focusing on the patient 
alone may not produce short and long-term benefits for 
patients. It is plausible that oncologists, trained specifically 
to respond to more active patients, can further enhance 
patient involvement and lead to a more successful consul-
tation. Recent studies have observed limited skills of the 
oncologists in shared decision-making claiming for the 
need of specific training to implement patient involve-
ment in clinical practice.37 38 There is the need to improve 
such skills but we need to know the differences between 
countries to generate a powerful and focused training 
programme. For this reason future research is warranted 
to explore cross cultural differences and the role of the 
oncologists to improve patient involvement.
limitation, strengths and future direction
This study has some limitations to be considered. First of 
all, in order to ensure that the oncologists were blind to 
their patient experimental group assignment, we devi-
ated from the accepted intervention process and did not 
provide copies of the completed QPS or QL for patients 
to use during their consultation to serve as a reminder to 
ask questions.
Furthermore, even if this study compared two active 
interventions (QPS vs. QL) and ensured participants 
blinding, the administration of the QL has been done 
without any previous coaching session as it was in some 
previous studies. In order to make the two intervention 
more similar and comparable the QL was manage inde-
pendently by the patients.
Of note, our sample was larger than most previous 
studies in the field13 16 18 19 and large enough to generalise 
our results to early stage female breast cancer patients 
with access to similar health services in Northern Italy. As 
far as we know, this is also the first study in Italy analysing 
audiotapes of routine oncological consultations, an 
approach which has inherent ecological validity and that 
is a recommended research tool3 39 which allow future 
analysis on information exchange.
Conclusions
Findings from the present study suggested that QPS have 
a similar impact on question asking compared with QL, if 
completed independently by the patients. Both could be 
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useful tools for stimulating patient’s participation during 
the consultation. Maybe the opportunity to rehearse 
their information needs before the consultation can help 
patients to better focus on them and to use the time spent 
during the consultation more efficiently, asking questions 
to their doctor that are more precise. This should be 
explored deeply in future studies along with the explora-
tion of which components of the interventions, focused 
on increasing patient participation, are really useful and 
efficacious. These interventions are relatively simple and 
inexpensive to disseminate in routine care with limited 
disruption to clinic flow.
Even if we did not found variables associated to ques-
tion asking, some patients might find the interventions 
more helpful than others. Further research is also needed 
to identify those patients to whom intervention are likely 
to be most beneficial and the role of the oncologist in 
leading the consultations.
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